NMPA Approval

Dextran 40 Sodium Chloride Injection

Approval Number

国药准字H41022582

Company信合援生制药股份有限公司

Registration Date

September 19, 2022

Previous Approval Numbers

国药准字H41022582

Drug Information

Generic Name

右旋糖酐40氯化钠注射液

Dosage Form

注射剂

Strength

500ml:30g右旋糖酐40与4.5g氯化钠

Drug Type

化学药品

Registration Date

September 19, 2022

Company Information

Applicant Company

Company Name信合援生制药股份有限公司

Company Address

固始县蓼城东路185号

Manufacturing Company

Company Name信合援生制药股份有限公司

Company Address

固始县城关轻工路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

右旋糖酐40氯化钠注射液 - NMPA 批准文号 | MedPath